Anavex Life Sciences Corp (AVXL)

[falconer66a]

No mystery.

Does anyone know how they calculated the $17?

Let's be honest. The financial advice community has no more information than we have (in fact, most in that crowd haven't the slightest understanding of elemental neuron chemistry and just how, if it would [it will] affect future AVXL share prices.)

Seventeen dollars might be a just-fine target sell price, for the client trader community. Those people, by and large (or, buy large) make their money by selling purchased equities at advanced prices. In this case, if the shares were to be purchased now, and sold at $17 in a few months, those making that trade would be smiling, with an approx. 300% gain. A whopper for them, after which they look for the next big buy-then-sell position. More power to 'em.

But those of us who understand the cell chemistry of Anavex 2-73, as proven in both murine (animal) and human trials, who likewise have studied the size of target patient populations (many, many millions), we know that a $17 sell target it utterly ridiculous. When mature, when Anavex 2-73 is prescribed for the many millions suffering from Alzheimer's, Parkinson's, amyolateral sclerosis, and a number of lesser (but serious) CNS (and other) debilitations, the AVXL share price will be three digits.

For me, my children and grand children will get my AVXL shares. I'll be nicely rewarded just with Anavex Life Science Corp. dividends.